Editorial Volume 11, Issue 1 pp 13—14

Atypical PKC: therapeutic target for Alzheimer’s?

Robert V. Farese 1, 2, , Mini P. Sajan 1, 2, ,

  • 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, University of South Florida, College of Medicine, Tampa, FL 33612, USA
  • 2 James A. Haley Veterans Administration Medical Center, Tampa, FL 33612, USA

received: October 2, 2018 ; published: December 20, 2018 ;

How to Cite

Copyright: Farese and Sajan. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.